Edward J. Ludwig's most recent trade in Boston Scientific Corp. was a trade of 4,000 Common Stock done at an average price of $104.6 . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific | Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 104.59 per share. | 29 May 2025 | 4,000 | 22,479 (0%) | 0% | 104.6 | 418,368 | Common Stock |
| Boston Scientific | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 26,479 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 105.48 per share. | 11 Feb 2025 | 12,000 | 24,398 (0%) | 0% | 105.5 | 1,265,815 | Common Stock |
| Boston Scientific | Edward J. Ludwig | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2025 | 3,000 | 36,398 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 91.63 per share. | 21 Nov 2024 | 4,877 | 39,398 (0%) | 0% | 91.6 | 446,902 | Common Stock |
| Boston Scientific | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,901 | 44,275 (0%) | 0% | 0 | Common Stock | |
| CVS Health | Edward J. Ludwig | Director | Purchase of securities on an exchange or from another person at price $ 53.88 per share. | 02 May 2024 | 1,000 | 21,630 (0%) | 0% | 53.9 | 53,879 | Common Stock |
| Boston Scientific | Edward J. Ludwig | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.37 per share. | 26 Apr 2024 | 9,818 | 51,192 (0%) | 0% | 17.4 | 170,539 | Common Stock |
| Boston Scientific | Edward J. Ludwig | Director | Sale of securities on an exchange or to another person at price $ 73.29 per share. | 26 Apr 2024 | 9,818 | 41,374 (0%) | 0% | 73.3 | 719,562 | Common Stock |
| Boston Scientific | Edward J. Ludwig | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2024 | 9,818 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | J. Edward Ludwig | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 7,000 | 9,818 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Ludwig Edward J. | Director | Sale of securities on an exchange or to another person at price $ 65.03 per share. | 13 Feb 2024 | 7,000 | 41,374 (0%) | 0% | 65.0 | 455,223 | Common Stock |
| Boston Scientific | Ludwig Edward J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.37 per share. | 13 Feb 2024 | 7,000 | 48,374 (0%) | 0% | 17.4 | 121,590 | Common Stock |
| CVS Health | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 2,422 | 14,522 | - | - | Share Credits | |
| CVS Health | Edward J. Ludwig | Director | Purchase of securities on an exchange or from another person at price $ 70.46 per share. | 03 Nov 2023 | 2,000 | 20,630 (0%) | 0% | 70.5 | 140,930 | Common Stock |
| CVS Health | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 2,068 | 11,816 | - | - | Share Credits | |
| Boston Scientific | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 3,946 | 41,382 | - | - | Deferred Stock Units | |
| Boston Scientific | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 2,984 | 44,366 | - | - | Deferred Stock Units | |
| CVS Health | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 1,323 | 9,681 | - | - | Share Credits | |
| CVS Health | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 94.93 per share. | 17 Nov 2022 | 131 | 18,630 (0%) | 0% | 94.9 | 12,436 | Common Stock |
| CVS Health | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 1,282 | 8,222 | - | - | Share Credits | |
| CVS Health | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 97.99 per share. | 11 May 2022 | 165 | 18,499 (0%) | 0% | 98.0 | 16,168 | Common Stock |
| Boston Scientific | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 4,877 | 41,374 (0%) | 0% | 0 | Common Stock | |
| CVS Health | Edward J. Ludwig | Director | Purchase of securities on an exchange or from another person at price $ 105.90 per share. | 10 Feb 2022 | 1,000 | 18,334 (0%) | 0% | 105.9 | 105,904 | Common Stock |
| CVS Health | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 1,354 | 6,905 | - | - | Share Credits | |
| CVS Health | Edward J. Ludwig | Director | Purchase of securities on an exchange or from another person at price $ 79.54 per share. | 05 Aug 2021 | 3,000 | 17,334 (0%) | 0% | 79.5 | 238,635 | Common Stock |
| CVS Health | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 1,490 | 5,586 | - | - | Share Credits | |
| Boston Scientific | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 4,763 | 37,436 | - | - | Deferred Stock Units | |
| CVS Health | Edward J. Ludwig | Director | Purchase of securities on an exchange or from another person at price $ 72.00 per share. | 17 Feb 2021 | 3,000 | 14,334 (0%) | 0% | 72 | 216,000 | Common Stock |
| CVS Health | Edward J. Ludwig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2020 | 1,893 | 3,942 | - | - | Share Credits |